{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:11:29Z","timestamp":1771855889483,"version":"3.50.1"},"reference-count":20,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/br.2017.896","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T07:29:30Z","timestamp":1492673370000},"page":"686-690","source":"Crossref","is-referenced-by-count":4,"title":["Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation"],"prefix":"10.3892","volume":"6","author":[{"given":"Zengxiang","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuangzhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoguang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"key20180107142909_b1-br-0-0-896","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/hrt.77.5.393","article-title":"Atrial fibrillation begets trouble","volume":"77","author":"Waktare","year":"1997","journal-title":"Heart"},{"key":"key20180107142909_b2-br-0-0-896","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1536\/ihj.13-254","article-title":"Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation","volume":"55","author":"Sasaki","year":"2014","journal-title":"Int Heart J"},{"key":"key20180107142909_b3-br-0-0-896","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European society of cardiology (ESC)","volume":"31","author":"European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery","year":"2010","journal-title":"Eur Heart J"},{"key":"key20180107142909_b4-br-0-0-896","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pharmthera.2011.02.002","article-title":"Mechanisms of termination and prevention of atrial fibrillation by drug therapy","volume":"131","author":"Workman","year":"2011","journal-title":"Pharmacol Ther"},{"key":"key20180107142909_b5-br-0-0-896","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2298\/MPNS1410334V","article-title":"Drug induced lung disease-amiodarone in focus","volume":"67","author":"Vasi\u0107","year":"2014","journal-title":"Med Pregl"},{"key":"key20180107142909_b6-br-0-0-896","doi-asserted-by":"crossref","first-page":"217","DOI":"10.59566\/IJBS.2014.10217","article-title":"Acute amiodarone pulmonary toxicity following lung resection","volume":"10","author":"Fadahunsi","year":"2014","journal-title":"Int J Biomed Sci"},{"key":"key20180107142909_b7-br-0-0-896","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinte.166.7.719","article-title":"Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials","volume":"166","author":"Lafuente-Lafuente","year":"2006","journal-title":"Arch Intern Med"},{"key":"key20180107142909_b8-br-0-0-896","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/europace\/euq450","article-title":"Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation","volume":"13","author":"Freemantle","year":"2011","journal-title":"Europace"},{"key":"key20180107142909_b9-br-0-0-896","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijcard.2011.06.012","article-title":"Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefits","volume":"155","author":"Camm","year":"2012","journal-title":"Int J Cardiol"},{"key":"key20180107142909_b10-br-0-0-896","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(02)00380-7","article-title":"SOCES Investigators: Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation","volume":"88","author":"de Paola","year":"2003","journal-title":"Int J Cardiol"},{"key":"key20180107142909_b11-br-0-0-896","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/hrt.2005.072322","article-title":"Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation","volume":"92","author":"Korantzopoulos","year":"2006","journal-title":"Heart"},{"key":"key20180107142909_b12-br-0-0-896","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2006.07.017","article-title":"Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter","volume":"118","author":"Kafkas","year":"2007","journal-title":"Int J Cardiol"},{"key":"key20180107142909_b13-br-0-0-896","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","article-title":"Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide\/Sotalol Comparator Study Group","volume":"79","author":"Vos","year":"1998","journal-title":"Heart"},{"key":"key20180107142909_b14-br-0-0-896","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/europace\/eun302","article-title":"Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate","volume":"11","author":"Fragakis","year":"2009","journal-title":"Europace"},{"key":"key20180107142909_b15-br-0-0-896","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"key20180107142909_b16-br-0-0-896","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/01.CIR.91.6.1799","article-title":"Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects","volume":"91","author":"Yang","year":"1995","journal-title":"Circulation"},{"key":"key20180107142909_b17-br-0-0-896","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0002-9149(97)00395-0","article-title":"Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function","volume":"80","author":"Stambler","year":"1997","journal-title":"Am J Cardiol"},{"key":"key20180107142909_b18-br-0-0-896","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199243010-00007","article-title":"Amiodarone: An overview of its pharmacological properties and review of its therapeutic use in cardiac arrhythmias","volume":"43","author":"Gill","year":"1992","journal-title":"Drugs"},{"key":"key20180107142909_b19-br-0-0-896","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.CIR.80.1.34","article-title":"Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects","volume":"80","author":"Mitchell","year":"1989","journal-title":"Circulation"},{"key":"key20180107142909_b20-br-0-0-896","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","article-title":"Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: Electrophysiological determinants of enhanced conversion efficacy","volume":"96","author":"Stambler","year":"1997","journal-title":"Circulation"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2017.896\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T17:41:08Z","timestamp":1719164468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,20]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/br.2017.896"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.896","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}